Global Life Sciences Research Market
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
 |
European Proteomics The European Proteomics market is driven by increase in the number of diseases. The market value of the Proteomics market was $ 3.28 billion in 2012 and is expected to be $ 7.35 billion by 2018, at a CAGR of 14.6%. The report “European Proteomics Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Proteomics Instrumentation Technologies, Proteomics Reagents and Proteomics Services. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Roche, etc. |
Upcoming |
|
|
Asian Proteomics The Asian Proteomics market is driven by increase in the number of diseases. The market value of the Proteomics market was $ 1.42 billion in 2012 and is expected to be $ 4.16 billion by 2018, at a CAGR of 19.8%. The report “Asian Proteomics Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Proteomics Instrumentation Technologies, Proteomics Reagents and Proteomics Services. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Water Corporation, Roche, etc. |
Upcoming |
|
|
Asian Proteomics Instruments The Asian proteomics market is driven by the increase in the number of diseases and the population suffering from these diseases. The report analyzes the market in terms of product type such protein microarray, spectroscopy, electrophoresis, X-ray crystallography, chromatography, electrophoresis, SPR systems, Protein Fractionation Systems. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Sigma-Aldrich Corporation, Danaher Corporation, and Water Corporation. |
Upcoming |
|
|
North America Proteomics Instruments The North American proteomics market is driven by the increase in the number of diseases and the population suffering from these diseases. The report analyzes the market in terms of product type such protein microarray, spectroscopy, electrophoresis, X-ray crystallography, chromatography, electrophoresis, SPR systems, Protein Fractionation Systems. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Sigma-Aldrich Corporation, Danaher Corporation, and Water Corporation. |
Upcoming |
|
|
European Proteomics Instruments The European proteomics market is driven by the increase in the number of diseases and the population suffering from these diseases. The report analyzes the market in terms of product type such protein microarray, spectroscopy, electrophoresis, X-ray crystallography, chromatography, electrophoresis, SPR systems, Protein Fractionation Systems. The key players of the market covered in this report are Thermo Fisher Scientific, Agilent technologies, Sigma-Aldrich Corporation, Danaher Corporation, and Water Corporation. |
Upcoming |
|
|
North American Microfluidics Market The North American Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which was valued at $669 million in 2013 and is poised to grow at a CAGR of 17.4% to reach $1496 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany) |
Upcoming |
|
|
European Microfluidics The European Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which was valued at $420 million in 2013 and is poised to grow at a CAGR of 15.2% to reach $852 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany) |
Upcoming |
|
|
Asian Microfluidics Market The Asian Microfluidics Market, mainly driven by rising incidences of diseases such as cancer, diabetes, infectious diseases, and cardiovascular diseases, brain disorders and sleep disorders which was valued at $369 million in 2013 and is poised to grow at a CAGR of 20.9% to reach $952 million by 2018. The Microfluidics market segmentation by type such as Polymer-based materials, glass-based materials, silicon-based materials, and other materials based Microfluidics. The main companies operating in this market and extensively covered in this report are Abbott laboratories, Agilent Technologies, Inc., Caliper Life sciences(Perkin Elmer) (U.S), Cepheid (U.S.), Beckman coulter/Danaher (U.S.), Johnson & Johnson (U.S.), Roche Diagnostics (Switzerland) and Siemens Healthcare (Germany) |
Upcoming |
|
|
North American Bio-MEMS Market The North American BIO-MEMS Devices Market, The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. BIO-MEMS market segmentation by Products such as DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators .The main companies operating in Bio-Chips and BIO-MEMS Devices market and extensively covered in this report are Abbott, Baxter, Becton Dickinson(BD), Caliper Life sciences, Cepheid, Boston Scientific, Analog Devices, Bluechiip, CapitalBio, Dolomite, Medronic, Roche diagnostics, St. Jude Medical and others. |
Upcoming |
|
|
European Bio-MEMS Market The European BIO-MEMS Devices Market, The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. BIO-MEMS market segmentation by Products such as DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators .The main companies operating in Bio-Chips and BIO-MEMS Devices market and extensively covered in this report are Abbott, Baxter, Becton Dickinson(BD), Caliper Life sciences, Cepheid, Boston Scientific, Analog Devices, Bluechiip, CapitalBio, Dolomite, Medronic, Roche diagnostics, St. Jude Medical and others. |
Upcoming |
|
|
Asian Bio-MEMS Market The Asian BIO-MEMS Devices Market, The usefulness of these devices is two-fold: for one, they improve medical device performance for the patient; and secondly, they offer competitive advantages to system manufacturers. BIO-MEMS market segmentation by Products such as DNA-Chips, Lab-on-chips, Drug delivery systems, Biosensors, Microfluidic Devices, Biomems implants, Silicon Microphones, Accelerometers, Gyroscopes, and microactuators .The main companies operating in Bio-Chips and BIO-MEMS Devices market and extensively covered in this report are Abbott, Baxter, Becton Dickinson(BD), Caliper Life sciences, Cepheid, Boston Scientific, Analog Devices, Bluechiip, CapitalBio, Dolomite, Medronic, Roche diagnostics, St. Jude Medical and others. |
Upcoming |
|
|
North American High Content analysis/Screening The North American High Content Screening market was valued at $161.8 million in 2013 and is expected to reach $280.7 million by 2018, growing at a CAGR of 11.7% from 2013 to 2018. High Content Screening market segmentation primarily based on product types, the market is categorized into instruments (Imaging and Analysis HCS Systems, Flow Cytometers), consumables (Reagents and Assay kits, Microplates and other consumables) , software, and services. Based on applications, the high content screening market is segmented into primary and secondary screening, target identification and validation, toxicity studies, and compound profiling. Among the various end users of high content screening, pharmaceutical and biotechnology companies lead the market. Major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (U.S.), PerkinElmer (U.S.), and GE Healthcare (U.K), Olympus (Japan), Life Technologies (U.S.), EMD Millipore (Germany), BD Bioscience (U.S.), Definiens AG (Germany), Yokogawa Electric Corporation (Japan), and TTP Labtech (U.S). |
Upcoming |
|
|
European High content analysis/Screening The European High Content Screening market was valued at $124.29 million in 2013 and is expected to reach $207.9 million by 2018, growing at a CAGR of 10.6% from 2013 to 2018. High Content Screening market segmentation primarily based on product types, the market is categorized into instruments (Imaging and Analysis HCS Systems, Flow Cytometers), consumables (Reagents and Assay kits, Microplates and other consumables) , software, and services. Based on applications, the high content screening market is segmented into primary and secondary screening, target identification and validation, toxicity studies, and compound profiling. Among the various end users of high content screening, pharmaceutical and biotechnology companies lead the market. Major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (U.S.), PerkinElmer (U.S.), and GE Healthcare (U.K), Olympus (Japan), Life Technologies (U.S.), EMD Millipore (Germany), BD Bioscience (U.S.), Definiens AG (Germany), Yokogawa Electric Corporation (Japan), and TTP Labtech (U.S). |
Upcoming |
|
|
Asian High content analysis/Screening The Asian High Content Screening market was valued at $55.75 million in 2013 and is expected to reach $101.74 million by 2018, growing at a CAGR of 12.8% from 2013 to 2018.High Content Screening market segmentation primarily based on product types, the market is categorized into instruments (Imaging and Analysis HCS Systems, Flow Cytometers), consumables (Reagents and Assay kits, Microplates and other consumables) , software, and services. Based on applications, the high content screening market is segmented into primary and secondary screening, target identification and validation, toxicity studies, and compound profiling. Among the various end users of high content screening, pharmaceutical and biotechnology companies lead the market. Major players in the market include Thermo Fisher Scientific (U.S.), Molecular Devices (U.S.), PerkinElmer (U.S.), and GE Healthcare (U.K), Olympus (Japan), Life Technologies (U.S.), EMD Millipore (Germany), BD Bioscience (U.S.), Definiens AG (Germany), Yokogawa Electric Corporation (Japan), and TTP Labtech (U.S). |
Upcoming |
|
|
North American High throughput screening The North American High Throughput Screening market was valued at $6454.3 million in 2013 and is expected to reach $9046.8 million by 2018, growing at a CAGR of 7.0% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland). |
Upcoming |
|
|
European High throughput screening The European High Throughput Screening market was valued at $3794.7 million in 2013 and is expected to reach $5194.3 million by 2018, growing at a CAGR of 6.5% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland). |
Upcoming |
|
|
Asian High throughput screening The Asian High Throughput Screening market was valued at $2547.3 million in 2013 and is expected to reach $3931.2 million by 2018, growing at a CAGR of 9.1% from 2013 to 2018. High Throughput Screening market is primarily categorized by technology, product, end user, and application. By technology, the HTS market is categorized into ultra high throughput screening (uHTS), cell-based assays, lab-on-a-chip, label-free technology, and bioinformatics. By product, the HTS market is segmented into instruments, consumables/reagents, and software and services. By end user, the High Throughput Screening market is categorized into pharmaceutical, biotechnology, academia and government, contract research organizations, and others. By application, the High Throughput Screening market is classified into target identification, primary screening, toxicology, stem cell biology, and others. Major players in the market include Agilent Technologies, Inc. (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.) and Tecan Group (Switzerland). |
Upcoming |
|
|
North American Proteomics Reagents The North American proteomics reagents market is driven by the increase in collaboration between companies and research Institutes and increasing R&D investments in research. The value of the proteomics market was $ 1.34 million in 2012, and is expected to reach $ 2.26 billion by 2018, at a CAGR of 8.2%. The report “North American proteomics reagents Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Immunoassay, Microarray, Spectroscopy, Electrophoresis, X-ray Crystallography, Chromatography and Protein Fractionation. The key players of the market covered in this report are Thermo Fisher Scientific, Life Technologies, Sigma- Aldrich Corporation and Bio-Rad laboratories. |
Upcoming |
|
|
European Proteomics Reagents The European proteomics reagent market is driven by the increase in collaboration between companies and research Institutes and increasing R&D investments in research. The value of the proteomics market was $ 1.23 billion in 2012, and is expected to reach $ 2.23 billion by 2018, at a CAGR of 10.3%. The report “European proteomics reagent Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Immunoassay, Microarray, Spectroscopy, Electrophoresis, X-ray Crystallography, Chromatography and Protein Fractionation. The key players of the market covered in this report are Thermo Fisher Scientific, Life Technologies, Bio-Rad laboratories, etc. |
Upcoming |
|
|
Asian Proteomics Reagents The Asian proteomics reagents market is driven by the increase in collaboration between companies and research Institutes and increasing R&D investments in research. The value of the proteomics market was $ 541 million in 2012, and is expected to reach $ 12.6 million by 2018, at a CAGR of 15.3%. The report “Asia proteomics reagent Market Forecast, 2012-2018”, analyzes the market in terms of product type such as Immunoassay, Microarray, Spectroscopy, Electrophoresis, X-ray Crystallography, Chromatography and Protein Fractionation. The key players of the market covered in this report are Thermo Fisher Scientific, Life Technologies Corporation, Bio-Rad laboratories, Agilent technologies, GE Healthcare, etc. |
Upcoming |
Life Sciences Research
